Trials / Terminated
TerminatedNCT00829049
Safety and Efficacy of Tazarotene Cream 0.1% Compared With Adapalene Gel 0.3% in the Treatment of Moderate to Severe Facial Acne Vulgaris
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 165 (actual)
- Sponsor
- Allergan · Industry
- Sex
- All
- Age
- 12 Years
- Healthy volunteers
- Not accepted
Summary
Comparison of the safety and efficacy of Tazarotene Cream 0.1% compared with Adapalene Gel 0.3% in treating moderate to severe facial acne vulgaris
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tazarotene Cream 0.1% | 1 pea-size amount, QD x 16 weeks |
| DRUG | Adapalene | 1 pea-size amount, QD x 16 weeks |
Timeline
- Start date
- 2007-10-01
- Primary completion
- 2008-10-01
- Completion
- 2008-10-01
- First posted
- 2009-01-26
- Last updated
- 2012-09-12
- Results posted
- 2012-09-12
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00829049. Inclusion in this directory is not an endorsement.